AbbVie vs Eli Lilly (ABBV vs LLY)
AbbVie (ABBV) vs Eli Lilly (LLY) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.
AbbVie (ABBV) and Eli Lilly (LLY) compete in healthcare and pharma. Here are AbbVie and Eli Lilly side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy AbbVie or Eli Lilly.
AbbVie vs Eli Lilly: the figures
| Figure | AbbVie | Eli Lilly |
|---|---|---|
| Share price | $294.83 (November 4, 2026) | $1,417.99 (November 4, 2026) |
| Market cap | $521.0 billion | $1.26 trillion |
| P/E (TTM) | 50.7x | 46.0x |
| Forward P/E | 18.2x | 28.3x |
| Revenue growth (quarter) | +10.3% | +38.6% |
| Net margin (TTM) | 15.7% | 31.9% |
| Net debt / EBITDA | 2.0x | 1.0x |
| Dividend yield | 2.42% | 0.49% |
| Beta | 0.19 | 0.39 |
AbbVie and Eli Lilly figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that AbbVie or Eli Lilly figure is not available, and we never estimate it.
3 key differences between AbbVie and Eli Lilly
- Growth: Eli Lilly grew sales +38.6% year on year in its latest quarter, against +10.3% for AbbVie.
- Profitability: for every 100 of sales, Eli Lilly keeps 31.9 as net profit and AbbVie keeps 15.7.
- Dividend: AbbVie yields 2.42% at today's price and Eli Lilly yields 0.49%.
AbbVie or Eli Lilly: which fits your profile
- If you want growth: Eli Lilly is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
- If you want income (dividends): AbbVie pays the higher dividend relative to its price.
- If you prefer caution: Eli Lilly has less debt relative to its profit, which usually gives more room in a bad year.
- If price is what matters most to you: Eli Lilly trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.
Neither AbbVie nor Eli Lilly wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.
How AbbVie and Eli Lilly make money
AbbVie (ABBV)
AbbVie earns its money from branded drugs grouped into therapeutic areas: Immunology, led by Skyrizi, Rinvoq and Humira, is the biggest, followed by Oncology (Imbruvica, Venclexta), Neuroscience (Vraylar, therapeutic Botox) and Aesthetics (cosmetic Botox, Juvederm). The United States is by far its largest market. Full AbbVie analysis.
Eli Lilly (LLY)
Eli Lilly sells prescription medicines. Its largest revenue source is tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, followed by Verzenio for breast cancer, Jardiance and Trulicity for diabetes, Taltz for immunology and Kisunla for Alzheimer's disease. The United States is its biggest market. Full Eli Lilly analysis.
Frequently asked questions: AbbVie vs Eli Lilly
Is AbbVie or Eli Lilly the better stock?
Choosing between AbbVie and Eli Lilly depends on what you are looking for. Eli Lilly is growing faster right now, and Eli Lilly trades on the lower P/E. Fintols does not tell you whether to buy AbbVie or Eli Lilly: it shows you the differences so you can decide.
Which pays a higher dividend, AbbVie or Eli Lilly?
As of November 4, 2026, AbbVie yields 2.42% and Eli Lilly yields 0.49%. Also check how much of their profit AbbVie and Eli Lilly pay out: if it is more than they earn, it cannot last.
Which is more expensive, AbbVie or Eli Lilly?
On P/E, AbbVie (50.7x) is more expensive than Eli Lilly (46.0x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.
Can I own both AbbVie and Eli Lilly?
Yes. Many people spread their money across several companies, such as AbbVie and Eli Lilly, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying AbbVie or Eli Lilly.
More comparisons with AbbVie or Eli Lilly
More companies like AbbVie and Eli Lilly: healthcare and pharma stocks. Educational content about AbbVie and Eli Lilly, not investment advice.